MAX Stock Overview
Focuses on investing in life sciences, fintech, environmental and renewables, and retail businesses in the United Kingdom. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Maxrets Ventures Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.022 |
| 52 Week High | UK£0 |
| 52 Week Low | UK£0 |
| Beta | -0.069 |
| 11 Month Change | -55.00% |
| 3 Month Change | -59.09% |
| 1 Year Change | -88.75% |
| 33 Year Change | -92.62% |
| 5 Year Change | n/a |
| Change since IPO | -91.18% |
Recent News & Updates
Recent updates
Shareholder Returns
| MAX | GB Pharmaceuticals | GB Market | |
|---|---|---|---|
| 7D | 0% | 4.5% | 2.2% |
| 1Y | -88.8% | 0.7% | 8.0% |
Return vs Industry: MAX underperformed the UK Pharmaceuticals industry which returned 0.7% over the past year.
Return vs Market: MAX underperformed the UK Market which returned 8% over the past year.
Price Volatility
| MAX volatility | |
|---|---|
| MAX Average Weekly Movement | 18.6% |
| Pharmaceuticals Industry Average Movement | 6.7% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: MAX's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: MAX's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 3 | n/a | maxrets.com |
Maxrets Ventures Plc focuses on investing in life sciences, fintech, environmental and renewables, and retail businesses in the United Kingdom. The company was formerly known as Greencare Capital plc. and changed its name to Maxrets Ventures Plc in January 2023.
Maxrets Ventures Plc Fundamentals Summary
| MAX fundamental statistics | |
|---|---|
| Market cap | UK£332.83k |
| Earnings (TTM) | -UK£478.00k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.7x
P/E RatioIs MAX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MAX income statement (TTM) | |
|---|---|
| Revenue | UK£0 |
| Cost of Revenue | UK£0 |
| Gross Profit | UK£0 |
| Other Expenses | UK£478.00k |
| Earnings | -UK£478.00k |
Last Reported Earnings
Oct 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.032 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did MAX perform over the long term?
See historical performance and comparison